From experiment to experience: Side effects of nonsteroidal anti-inflammatory drugs

The American Journal of Medicine

Volumn 74, Issue 5, 1983, Pages 820-828

  Coles, L Stephen ^a   Fries, James F ^a   Kraines, R Guy ^a   Roth, Sanford H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENOPROFEN; IBUPROFEN; MECLOFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; TOLMETIN;

ADVERSE DRUG REACTION; AUDITORY SYSTEM; CLINICAL TRIAL; DIGESTIVE SYSTEM; DRUG COMPARISON; DRUG THERAPY; EDEMA; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INTOXICATION; JOINT; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT; RASH; SKIN TOXICITY; THERAPY; TINNITUS;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; HUMAN; PATIENT COMPLIANCE; QUESTIONNAIRES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0020574356     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(83)91073-2     Document Type: Article

References (54)

1. Prevalence of rheumatic disease
2. Lilly halts world sales of arthritis drug
3. Drug lag 1980 The missing medicines
4. Piroxicam (Feldene)
5. Time-oriented patient records and a computer data bank
6. TOD: A software system for the ARAMIS data bank
7. Clinical data banks and clinical decisions
8. Characteristics of respondents and non-respondents to a mailed questionnaire
9. A multicenter double-blind crossover comparison study of aproxen and aspirin in patients with rheumatoid arthritis
10. A parallel study of naproxen and aspirin in rheumatoid arthritis
11. Naproxen: Long-term study in rheumatoid arthritis and “placebo-pulse”
12. Long-term experience with naproxen in patients with rheumatoid arthritis and concomitant upper-gastrointestinal disease
13. Naprosyn
14. Choline magnesium trisalicylate versus ibuprofen in rheumatoid arthritis
15. A six-month double-blind trial of ibuprofen and indomethacin in osteoarthritis
16. Comparison of sulindac with ibuprofen in the management of rheumatoid arthritis
17. Tolmetin sodium vs. ibuprofen in rheumatoid arthritic patients previously untreated with either drug: a double-blind crossover study
18. Fenoprofen calcium in rheumatoid arthritis: a controlled double-blind crossover evaluation
19. Some problems in the interpretation of clinical trials; longterm parallel study of fenoprofen in rheumatoid arthritis
20. Fenoprofen in rheumatoid arthritis: a controlled crossover multi-centre study
21. Comparison of benefitto-risk ratios of aspirin and fenoprofen: controlled multicenter study in rheumatoid arthritis
22. Fenoprofen therapy in large joint osteoarthritis: double-blind comparison with aspirin and longterm experience
23. Controlled evaluation of fenoprofen in geriatric patients with osteoarthritis
24. Multiclinic double-blind comparison of tolmetin with aspirin in the treatment of rheumatoid arthritis
25. A double-blind comparison of the efficacy and side effect liability of tolmetin and indomethacin
26. Tolmetin: longterm therapy in patients with rheumatoid arthritis
27. Rheumatoid arthritis: long-term treatment with tolmetin sodium
28. Tolmetin with acetaminophen in the treatment of rheumatoid arthritis
29. A clinical assessment in general practice of sulindac
30. Sulindac: clinical results of treatment of osteoarthritis
31. Long-term double-blind comparison of sulindac and aspirin in the treatment of osteoarthritis. Special Report, Clinical Evaluations of Clinoril
32. Long-term multiclinic evaluation of sulindac and aspirin in rheumatoid arthritis
33. The sulindac profile: use of sulindac in hospital and private practice—multicenter study in general practice
34. A multicenter trial of sulindac in osteoarthritis of the hip
35. A multicenter trial with thenew antiinflammatory drug sulindac—analysis of its efficacy and tolerance
36. An antirheumatic agent in general practice: results of a study of the antirheumatic agent sulindac (Imbaral) by general practitioners
37. Clinical pharmacology studies of sodium meclofenamate (Meclomen)
38. Sodium meclofenamate (vs. placebo) in the treatment of rheumatoid arthritis
39. Sodium meclofenamate (Meclomen) vs. aspirin for rheumatoid arthritis
40. Safety of sodium meclofenarrtate (Meclomen)
41. A patient-administered questionnaire for arthritis assessment
42. Creative penmanship in animal testing prompts PDA controls
43. A randomized blind crossover trial of six nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis
44. Food and Drug Administration's adverse drug reaction monitoring program
45. A method for postmarketing screening of adverse reactions to drugs—initial results
46. A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents